BI-7273 NEW
| Price | $32 | $72 | $113 |
| Package | 1mg | 5mg | 10mg |
| Supply Ability: | 10g |
| Update Time: | 2026-07-14 |
Product Details
| Product Name: BI-7273 | CAS No.: 1883429-21-7 |
| Purity: 98.84% | Supply Ability: 10g |
| Release date: 2026/07/14 |
Product Introduction
Bioactivity
| Name | BI-7273 |
| Description | BI-7273 is an effective, specific, BRD9 BD Inhibitor, which can infiltrate cell. |
| Cell Research | Cells are grown in 50 μL medium as specified by the supplier for 7 days starting with 500 and with 1000 cells per well of a 384 well plate in the presence of varying concentrations of compound before measuring viability via cellular ATP levels using the cell titer glow assay. |
| In vitro | BI-7273 blocks EOL-1 cell proliferation with EC50 of 1400 nM. BI-7273 (1 μM) is active in U2OS cell lines. BI-7273 (10 μM) shows an inhibition below 40% against 31 kinases[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+90% Saline : 0.88 mg/mL (2.49 mM), Solution. H2O : < 1 mg/mL (insoluble or slightly soluble) Ethanol : 65 mg/mL (183.92 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 1 mg/mL (2.83 mM), Sonication is recommended. DMSO : 21.43 mg/mL (60.64 mM), Sonication is recommended. |
| Keywords | Inhibitor | inhibit | EpigeneticReaderDomain | Epigenetic Reader Domain | BRD9 | BRD7 | BI-7273 | BI7273 | BI 7273 |
| Inhibitors Related | ABBV-744 | CeMMEC1 | 3-methyl-1,2,3,4-tetrahydroquinazolin-2-one | (+)-JQ-1 | J-147 | 5-Ph-IAA | Curcumin | dBET6 | Naphthol AS-E | Revumenib | JQ-1 (carboxylic acid) | Bisdemethoxycurcumin |
| Related Compound Libraries | Histone Modification Compound Library | Reprogramming Compound Library | Bioactive Compound Library | Epigenetics Compound Library | Chromatin Modification Compound Library | Multi-Target Compound Library | Inhibitor Library | NO PAINS Compound Library | PPI Inhibitor Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $932.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-07-14 | |
| $1400.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-07-15 | |
| $6.00 |
VIP3Y
|
Henan Fengda Chemical Co., Ltd
|
2026-07-09 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY